Eosinophilic Esophagitis (EoE), often referred to as “asthma of the esophagus”, is a chronic allergic/immune condition, which tends to reflect many similar clinical and pathophysiologic characteristics as with asthma. It is characterized by the inflammation of esophagus, and hence, termed as an atopic inflammatory disease of the esophagus.
Eosinophilic Esophagitis Market
DelveInsight's "Eosinophilic Esophagitis Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Eosinophilic Esophagitis, historical and forecasted epidemiology as well as the Eosinophilic Esophagitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Eosinophilic Esophagitis Epidemiology
The Eosinophilic Esophagitis epidemiology division provide insights about historical and current Eosinophilic Esophagitis patient pool and forecasted trend for every seven major countries.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
According to DelveInsight analysis, Prevalence of EoE is higher among men than women.
Eosinophilic Esophagitis Drug Chapters
Drug chapter segment of the Eosinophilic Esophagitis report encloses the detailed analysis of Eosinophilic Esophagitis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Eosinophilic Esophagitis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
The dynamics of Eosinophilic Esophagitis market (EoE) is anticipated to change during the forecast period, owing to the expected launch of emerging therapies during the forecast period of 2019-2028.Some of the key players in Eosinophilic Esophagitis market include-
-
Dr. FalkPharma
-
Regeneron Pharmaceuticals, Inc. /Sanofi
-
Adare Pharmaceuticals
-
Shire
About Delveinsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.